Introduction {#s1}
============

Central airway obstruction (CAO)^\[[@b1]\]^ and tracheoesophageal fistula (TEF)^\[[@b2],\ [@b3]\]^ are challenging clinical conditions, which might be caused by both malignant and benign primary diseases. CAO was defined as occlusion of \> 50% of the trachea, main bronchi, bronchus intermedius, or a lobar bronchus. It could be classified into extrinsic compression or intrinsic stenosis or the mixed type. With the development of rigid and flexible bronchoscopy^\[[@b4]\]^, airway stent placement becomes the effective and optimal regimen for airway stenosis^\[[@b5]\]^, which could maintain luminal patency for CAO and establish airway integrity for TEF^\[[@b6],\ [@b7]\]^, and relieve symptoms rapidly^\[[@b8]\]^.

The application scenarios of airway stent placement varied, including anesthesia approach, airway management, flexible or rigid bronchoscopy types, monitoring equipment, post-anesthesia care facility and emergency treatment support, *etc*.^\[[@b9],\ [@b10]\]^. With the development of new technologies, bronchial stenting and laser airway surgery is moving from the operating room to the intervention room^\[[@b10]\]^. While the risk of stent placement and tumor debulking still exists^\[[@b11],\ [@b12]\]^, and some researchers even suggested that stenting and laser surgery should not take place outside the operating room^\[[@b10]\]^. The American Society of Anesthesiologists (ASA) suggested that non-operating room anesthetizing locations should have appropriate gas supplies and gas scavenging, sufficient space to accommodate necessary equipment and personnel, expeditious access to the patient, appropriate monitoring equipment, and a post-anesthesia care facility. So far, many studies have focused on the different anesthesia management during airway stent placement^\[[@b12],\ [@b13]\]^, while few paid attention on the effect of procedure scenarios. This study aimed to make clinical comparison of airway stent placement in intervention room and operating room, and to propose possible ideas of scenario selection according to patients\' status.

Materials and methods {#s2}
=====================

Patients {#s2-1}
--------

This is a retrospective case-control study. Patients who underwent airway stent placement from January 2014 to January 2018 in the Department of Thoracic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine were consecutively included. The information was collected from the clinic or electronic medical record system. Patients with CAO caused by benign and malignant airway neoplasm or extrinsic compression, and tracheoesophageal fistula were included, and then they received therapeutic flexible or rigid bronchoscopy in the intervention room or in the operating room. The main symptoms of the patients were dyspnea and dysphagia, and there are many grading systems^\[[@b1]\]^. In this study, dysphagia and dyspnea were graded according to the previous reported methods^\[[@b14]\]^. Charlson comorbidity index (CCI) and Karnofsky performance status (KPS) of the patients were assessed. All patients were included with written informed consent under institutional review board-approved protocols of the First Affiliated Hospital, Zhejiang University School of Medicine.

Airway stent placement procedure {#s2-2}
--------------------------------

As reported in our previous study^\[[@b6]\]^, airway stent placement in the intervention room were conducted by therapeutic flexible bronchoscopy under local anesthesia by sprinkling 2% lidocaine via the catheter. And general anesthesia was required for rigid bronchoscopy in the operating room. Stenosis position or fistula was firstly checked, and the guide-wires were inserted and then the stents were released by the bronchoscopy-guided delivery system. Straight or Y-shaped self-expanding covered metallic stents (SEMS) or silicone stents were used in our center. Of note, two cases received extracorporeal membrane oxygenation (ECMO) supported airway tumor debulking and stent placement procedure in the operating room under general anesthesia. All patients were regularly followed up by bronchoscope and telephone calls. The last follow-up time was July 1st, 2018.

Statistical analysis {#s2-3}
--------------------

The count materials are expressed as number and percentage, and examined by *Chi-square* analysis (*χ*^2^), and the measuring materials are expressed as Mean±SD and examined by Student\'s *t*-test. All analyses were conducted using the SPSS 22.0 software (IBM SPSS Inc. United States). Statistical significance was set at *P* \< 0.05 (All *P* values presented were 2-sided).

Results {#s3}
=======

Clinical efficacy and complications {#s3-1}
-----------------------------------

A total of 82 patients who received stent placement were included in this study. The mean ages were 62.03 and 63.06 years-old for patients in the intervention room and the operating room, respectively. There was no significantly statistical difference for gender, primary diseases, drinking status, smoking status, clinical manifestation, pre-stent therapy, and location of the lesion between the two groups, as shown in [Tab 1](#Table1){ref-type="table"}. Compared with those in the operating room, patients in the intervention room had lower CCI scores (less than 4 points) (*P*=0.018) and underwent less Y-shaped stents (*P* \< 0.001).

###### 

Baseline characteristics of stent placement in intervention room and operating room.

  Variables                    Intervention room (*n*=39)   Operating room (*n*=43)   *P*              
  ---------------------------- ---------------------------- ------------------------- ------- -------- ----------
  Gender                                                                                               0.571
    Male                       28                           71.79%                    32      74.42%   
    Female                     10                           25.64%                    11      25.58%   
  Age (yr)                     62.03±10.56                  63.06±11.50               0.520            
  Primary disease                                                                                      0.477
    Lung cancer                18                           46.15%                    15      34.88%   
    Esophageal cancer          14                           35.90%                    21      48.84%   
    Others                     7                            17.95%                    7       16.28%   
  Drinking                                                                                             0.313
    Yes                        19                           48.72%                    23      53.49%   
    No                         13                           33.33%                    17      39.53%   
    Unknown                    7                            17.95%                    3       6.98%    
  Smoking                                                                                              0.317
    Yes                        16                           41.03%                    20      46.51%   
    No                         16                           41.03%                    20      46.51%   
    Unknown                    7                            17.95%                    3       6.98%    
  Charlson comorbidity index                                                                           0.018
     \< 4                      18                           46.15%                    13      30.23%   
    ≥5                         14                           35.90%                    28      65.12%   
    Unknown                    7                            17.95%                    2       4.65%    
  Clinical manifestation                                                                               0.815
    Obstruction\#              27                           69.23%                    28      65.12%   
    Fistula                    12                           30.77%                    15      34.88%   
  Pre-stent therapy                                                                                    1.000
    Surgery                    18                           46.15%                    19      44.19%   
    Others\*                   21                           53.85%                    24      55.81%   
  Location                                                                                             0.066
    Above the carina           21                           53.85%                    32      74.42%   
    Below the carina           18                           46.15%                    11      25.58%   
  Y-shaped stent                                                                                       \< 0.001
    No                         34                           87.18%                    9       20.93%   
    Yes                        5                            12.82%                    34      79.07%   

The clinical efficacy was assessed by rapid clinical response, post-stent complications and survival status. Both groups had significant KPS improvement after stent placement, as shown in [Fig 1](#Figure1){ref-type="fig"}. Patients in the operating room had better clinical response (*P*=0.026), more stents placed (*P* \< 0.001), and longer stents placed (*P* \< 0.001), as shown in [Tab 2](#Table2){ref-type="table"}. There was no significant difference of post-stent complications and stent placement time between the two groups. The detailed information of post-stent complications was shown in [Tab 3](#Table3){ref-type="table"}. The percentages of tumor debulking and balloon dilatation procedure were also compared between the intervention room and operating room, and there was a trend that more companion procedures of airway stent placement were conducted in the operating room (*P*=0.051).

![KPS score change for patients before and after stent placement in the intervention room and the operating room. \*: *P* \< 0.05. KPS: Karnofsky performance status.](zgfazz-23-6-451-1){#Figure1}

###### 

Clinical assessment of stent placement in intervention room and operating room

  Variables                                Intervention room (*n*=39)   Operating room (*n*=43)   *P*                 
  ---------------------------------------- ---------------------------- ------------------------- ---------- -------- ----------
  Clinical response\*                                                                                                 0.026
    No                                     25                           64.10%                    16         37.21%   
    Yes                                    14                           35.90%                    27         62.79%   
  Number of stent                                                                                                     \< 0.001
    1                                      38                           97.44%                    26         60.47%   
    2                                      1                            2.56%                     16         37.21%   
    3                                      0                            0.00%                     1          2.33%    
  Tumor debulking and balloon dilatation                                                                              0.051
    No                                     32                           82.05%                    26         60.47%   
    Yes                                    7                            17.95%                    17         39.53%   
  Complication                                                                                                        0.278
    No                                     16                           41.03%                    23         53.49%   
    Yes                                    23                           58.97%                    20         46.51%   
  Length of stent (mm)                     43.08±21.68                  80.53±38.21               \< 0.001            
  Stent placement time (min)               41.97±38.54                  68.62±73.92               0.061               
  Survival                                                                                                            0.503
    No                                     14                           35.90%                    19         44.19%   
    Yes                                    25                           64.10%                    24         55.81%   

###### 

Detailed information of complications after stent placement in intervention room and operating room

  Variables              Intervention room (*n*=39)   Operating room (*n*=43)   *P*             
  ---------------------- ---------------------------- ------------------------- ----- --------- -------
  Vocal cord paralysis                                                                          0.665
    No                   36                           92.31%                    41    95.35%    
    Yes                  3                            7.69%                     2     4.65%     
  Pulmonary infection                                                                           
    No                   37                           94.87%                    41    95.35%    1.000
    Yes                  2                            5.13%                     2     4.65%     
  Hemorrhage                                                                                    0.617
    No                   38                           97.44%                    40    93.02%    
    Yes                  1                            2.56%                     3     6.98%     
  Restenosis                                                                                    0.749
    No                   33                           84.62%                    38    88.37%    
    Yes                  6                            15.38%                    5     11.63%    
  Pneumothorax                                                                                  1.000
    No                   39                           100.00%                   41    95.35%    
    Yes                  0                            0.00%                     1     2.33%     
  Fistula                                                                                       0.715
    No                   37                           94.87%                    41    95.35%    
    Yes                  2                            5.13%                     2     4.65%     
  Granulation                                                                                   0.910
    No                   35                           89.74%                    32    74.42%    
    Yes                  4                            10.26%                    11    25.58%    
  Poor expanding                                                                                1.000
    No                   39                           100.00%                   42    97.67%    
    Yes                  0                            0.00%                     1     2.33%     
  Atelectasis                                                                                   0.223
    No                   37                           94.87%                    43    100.00%   
    Yes                  2                            5.13%                     0     0.00%     
  Stent migration                                                                               0.715
    No                   36                           92.31%                    38    88.37%    
    Yes                  3                            7.69%                     5     11.63%    
  Stent replacement                                                                             0.241
    No                   30                           76.92%                    38    88.37%    
    Yes                  9                            23.08%                    5     11.63%    
  Mucous plugging                                                                               1.000
    No                   34                           87.18%                    37    86.05%    
    Yes                  5                            12.82%                    6     13.95%    

ECMO supported airway debulking procedure and stent placement in the operating room {#s3-2}
-----------------------------------------------------------------------------------

A 57-year old female with poorly differentiated squamous cell carcinoma of the left lower lobe was admitted to the hospital for dyspnea, cough and blood in sputum. She was diagnosed as cT2N2M1b (stage IV) lung cancer with metastasis in the adrenal gland 4 years ago, and received 5 times chemotherapy of gemcitabine plus cisplatin until Sep 12, 2015. The central type carcinoma caused obstruction and inflammation of the left lower lobe. The pre-operation CT scans suggested that the tumor had invaded the left main bronchus ([Fig 2A](#Figure2){ref-type="fig"} and [Fig 2B](#Figure2){ref-type="fig"}), and there was a trend for the tumor to further invade the right main bronchus with the disease progress, which could cause life-threatening death. Under this circumstance, an ECMO-supported airway tumor excavation by rigid bronchoscopy was performed. The left main bronchus was excavated to 4.5 cm, but the bronchial opening of left upper and lower lobe still could not be seen. The ECMO was removed one day after surgery, and the post-operation bronchoscopy was shown in [Fig 3A](#Figure3){ref-type="fig"}, [Fig 3B](#Figure3){ref-type="fig"}, [Fig 3C](#Figure3){ref-type="fig"}. The patient underwent airway stent placement under general anesthesia with endotracheal intubation 20 days later. Two Y-shaped stents were placed in the left and right main bronchus, the right middle and upper bronchus, respectively ([Fig 3D](#Figure3){ref-type="fig"}, [Fig 3E](#Figure3){ref-type="fig"}, [Fig 3F](#Figure3){ref-type="fig"}) and there was much phlegm in the airway. The post-stent CT scans suggested the main airway and right bronchus were unobstructed ([Fig 2C](#Figure2){ref-type="fig"} and [Fig 2D](#Figure2){ref-type="fig"}). This patient received several times of sputum aspiration by bronchoscopy and was still alive until the last follow-up time.

![Case 1. Pre-stent lung window (A) and mediastinal widow (B) of the ECMO supported stenting case, and the red arrow suggested the location of tumor. Post-stent lung window (C) and mediastinal widow (D) of the case, and the red arrow suggested the stent position.](zgfazz-23-6-451-2){#Figure2}

![Bronchoscopy of pre-stent (A, B and C) and post-stent (D, E and F) images. A: Tumor invading carina from the view of main trachea. B: Amplified view of A. Left main bronchus was blocked by tumor. C: The right bronchus was also involved by the tumor. D: Stent was placed in the trachea. E: Stent was placed above the carina to prevent obstruction of main trachea. F: The Y-shaped stent was also placed in right trachea to prevent obstruction of right trachea.](zgfazz-23-6-451-3){#Figure3}

There was another case benefited from the ECMO supported emergency CAO relieving by tumor debulking in the operating room. A 54-year old man was admitted to our department for cough, blood in sputum and dyspnea and was diagnosed as squamous cell carcinoma of the trachea. As shown in [Fig 4A](#Figure4){ref-type="fig"} and [Fig 4B](#Figure4){ref-type="fig"}, the main trachea was obstructed and the enlarged subcarina lymph nodes compressed the left and right main bronchus. The patient suddenly occurred decline of partial pressure of oxygen and severe dyspnea, and ECMO supported trachea neoplasm debulking and airway remodeling were conducted after the evaluation of the anesthesiologist. The patient was in a stable condition after the procedure, and then the Y-shaped stents were placed by rigid bronchoscopy under general anesthesia 8 d later, as shown in [Fig 4C](#Figure4){ref-type="fig"} and [Fig 4D](#Figure4){ref-type="fig"}. The patients was still alive until the last follow-up time.

![Case 2. Pre-stent lung window (A) and mediastinal widow (B) of the ECMO supported stenting case, and the red arrow suggested the location of tumor. Post-stent lung window (C) and mediastinal widow (D) of the case, and the red arrow suggested the stent position.](zgfazz-23-6-451-4){#Figure4}

Discussion {#s4}
==========

The current study made clinical comparison of airway stent placement in different application scenarios. Clinical performance, post-stent complications and survival of airway stent placement in the intervention room and the operating room were compared. Our study found that more complicated procedures were performed in the operating room, including more stents, more Y-shaped stents and stents with longer length. On the other hand, patients underwent airway stent placement in the operating room had higher CCI scores (≥5 points). An ECMO supported stent placement and tumor debulking procedure was performed in the operating room, which suggested that the operating room could provide definitive security support.

For patients with CAO and TEF, airway stent placement could timely provide symptom palliation and improve survival and quality of life^\[[@b15],\ [@b16]\]^. The application scenarios of airway stent placement, stent types, anesthesia methods, bronchoscopy types, operating doctor\'s experience and nursing care varied, which could inevitably affect the safety and efficacy. Some researchers have suggested that patients\' safety should always be a primary consideration, and bronchial stenting and laser airway surgery should not take place outside the operating room^\[[@b10]\]^. Operating room could provide adequate safety support for high risk intervention procedure, such as necessary equipment and personnel. The high-tech platform including ECMO, monitoring equipment, airway management equipment, rescue drugs and equipment for emergencies and the multidisciplinary team consisting of anesthesiologists, thoracic surgeons, and intervention experts could ensure patient\'s safety made further treatment possible^\[[@b17]\]^. Airway stent placement is always risky, and some studies have suggested that it should only be performed at specialized centers by experienced physicians^\[[@b18]\]^.

Stent-related complications are inevitable, and many studies have reported these complications^\[[@b9],\ [@b18]-[@b21]\]^. In this study, post-stent complications were analyzed, including pulmonary infection, hemorrhage, restenosis, pneumothorax, fistula, granulation, poor expanding, atelectasis, stent migration and replacement, and mucous plugging. Airway stent placement in the operating room suggested lower rate of total complications than in the intervention room. Besides, more complicated procedures were conducted in the operating room, including two cases of ECMO supported tumor debulking and airway stent placement. Respiratory support with ECMO during stent placement have been reported in several studies^\[[@b22],\ [@b23]\]^, and most cases receive ECMO in the intensive care unit. Although potentially life-threatening complications exist, such as bleeding, hemolysis, air leakage, and thrombosis^\[[@b24]\]^, ECMO could provide sufficient oxygenation during airway interventional procedures and definitive airway security. It has been reported that even the rapid bedside ECMO could save patients\' life in experienced centers, and the complications could be managed by an experienced ECMO team^\[[@b25]\]^. In our study, the ECMO supported tumor debulking procedures were conducted in the operating room, which further ensured the security for high-risk patients and emergencies.

The material quality and shapes of airway stents varied. In this study, the main types were straight or Y-shaped SEMS or silicone stents. The Food and Drug Administration have called for restraint of metallic stents for benign airway disorders in 2005^\[[@b26]\]^, considering the effects of complications on the long-term survival of patients with benign diseases. However, many studies further reported the safety and efficacy of SEMS in benign^\[[@b27]\]^ and malignant^\[[@b17],\ [@b19]\]^ airway stenosis. Ayub *et al*. suggested that silicone stents have shown low complication rates and can ultimately be removed and should be first choice for patients with benign stenosis^\[[@b18]\]^. For malignant CAO patients with shorter life expectancy, both the SEMS and silicone stents seem to have similar efficacy and safety profile^\[[@b28]\]^. Matsumoto *et al*. even suggested that the combination stenting with silicone and metallic stents is a safe and beneficial procedure for patients with extended malignant airway stenosis^\[[@b29]\]^. More well-designed studies with large sample volume are warranted to further investigate this issue.

Careful patient selection is of outmost importance for a good outcome after airway stenting^\[[@b4]\]^. So far, there was no systematic selection process for higher risk CAO patients undergoing airway stent placement and this is the first time to compare different procedure scenarios. The patients\' CCI scores were higher in the operating room, and they had lower rates of post-stent complications, which indicated that higher risk patients could benefit from the operating room scenarios. Extremely high risk patients and emergency cases could benefit from the ECMO technique. Thus, preoperative evaluation and standard patient selection were important, for the consideration of both efficacy and security. This study proposed the idea that patients of different risk intervals should be evaluated and treated under standardized and personalized protocols, and more studies could further investigate this filed in the future.

In conclusion, patients with benign or malignant CAO could benefit from the operating room scenario, and airway stent placement in the operating room might be more suitable for patients with higher CCI scores and receiving more complicated procedures (more, longer, and Y-shaped stents).

Patients with benign or malignant CAO could benefit from the operating room scenario, and airway stent placement in the operating room might be more suitable for patients with higher CCI scores and receiving more complicated procedures (more, longer, and Y-shaped stents).
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